Summary
The Veeva Pulse Content Metrics Report 2022 is a technical report that presents preliminary findings on the changing landscape of commercial content in the pharmaceutical industry. It outlines the increasing demand for personalized and compliant materials, driven by a surge in new drug launches and the necessity for rapid delivery to healthcare professionals. The report documents that, on average, marketers take 21 days to complete the content lifecycle, with significant approval delays noted. It details the growth of digital content, which has outpaced print materials, and emphasizes the need for companies to adopt agile content solutions to enhance efficiency. The report is based on anonymized data from 350 global pharma leaders and provides benchmarks for content performance, highlighting opportunities for improvement in content operations. It also discusses the importance of a modular content strategy to streamline the creation and approval process, thereby reducing bottlenecks and accelerating time to market.
